Literature DB >> 8154648

Thrombolytic agents: the science of the art of choosing the better treatment.

M E Farkouh, J D Lang, D L Sackett.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8154648     DOI: 10.7326/0003-4819-120-10-199405150-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Number needed to treat is a simple measure of treatment efficacy for clinicians.

Authors:  S V Rajkumar; P Sampathkumar; A B Gustafson
Journal:  J Gen Intern Med       Date:  1996-06       Impact factor: 5.128

Review 2.  Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Authors:  J C Gillis; K L Goa
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

3.  Cost-effectiveness of thrombolytics: a simplified model.

Authors:  Sule Apikoğlu Rabuş; Fikret Vehbi Izzettin; Mesut Sancar; Murat Bülent Rabuş; Cevat Kirma; Cevat Yakut
Journal:  Pharm World Sci       Date:  2005-06

4.  The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic model.

Authors:  Luke Vale; Harvey Steffens; Cam Donaldson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection.

Authors:  Dilip Nathwani; Oliver A Cornely; Anke K Van Engen; Olatunji Odufowora-Sita; Peny Retsa; Isaac A O Odeyemi
Journal:  J Antimicrob Chemother       Date:  2014-08-05       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.